A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

American Journal of Hematology, EarlyView.

https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25100?af=R

Source: American Journal of Hematology - April 18, 2018 Category: Hematology Authors: JianLi , Xu ‐FeiHuang , Qian‐QianCai , ChenWang , HaoCai , HaoZhao , LuZhang , Xin‐XinCao , Robert PeterGale , Dao‐binZhou Source Type: research

More News: Dexamethasone | Hematology | Revlimid | Skin | Study